Investments - MedicBeacon Narrative (Details) - MediBeacon Inc. - USD ($)	1 Months Ended	2 Months Ended	12 Months Ended
	Jan. 31, 2025	Mar. 05, 2025	Dec. 31, 2024	Dec. 31, 2023	Mar. 31, 2025	Dec. 31, 2022
Schedule of Investments [Line Items]
Beneficial ownership percentage			45.90%	46.20%
Huadong
Schedule of Investments [Line Items]
Beneficial ownership percentage			45.90%	46.20%		47.20%
Ownership percentage, fully diluted basis			40.10%
Huadong | Forecast
Schedule of Investments [Line Items]
Beneficial ownership percentage					44.70%
Ownership percentage, fully diluted basis					39.70%
Life Sciences
Schedule of Investments [Line Items]
Equity method investments			$ 0	$ 0		$ 0
Gain on sale of investments				3,800,000
Realized loss, equity issuance				3,800,000
Cumulative unrecognized loss on equity method investments			17,000,000
Life Sciences | Huadong | Forecast
Schedule of Investments [Line Items]
Convertible notes and accrued interest converted to stock, in process		$ 7,500,000
Life Sciences | Convertible Debt
Schedule of Investments [Line Items]
Realized loss on equity method investment				4,700,000
Life Sciences | Convertible Debt | Subsequent Event
Schedule of Investments [Line Items]
Convertible notes and accrued interest converted to stock	$ 12,900,000
Notes Receivable | Life Sciences
Schedule of Investments [Line Items]
Notes receivable, face amount			$ 2,300,000
Notes receivable interest rate, percentage			12.00%
Notes receivable term			3 years
Realized loss			$ 2,300,000
Notes receivable			12,000,000	9,700,000
Interest income			1,400,000	500,000
Accrued interest receivable			$ 1,700,000	$ 300,000